Dr. Janet Pope: Two JAK Studies
Dr. Janet Pope discusses abstracts 962 and 963 as presented at the ACR/ARHP Annual Meeting in Chicago.
Audio Highlights and Interviews from Day 1 at the ACR 2018 meeting - LISTEN HERE
Audio Highlights and Interviews from Day 2 at the ACR 2018 meeting - LISTEN HERE
Dr. Kelly Krohn: Update on Osteoporosis Sessions
Dr. Kelly Krohn discusses exciting osteoporosis sessions presented at the ACR/ARHP annual meeting in Chicago.
Dr. Cassie Calabrese: IgG4-Related Disease
Dr. Cassie Calabreses discusses an IgG4-related disease abstract presented at the ACR/ARHP Annual Meeting in Chicago.
Four years ago, the genesis of this session (technology tools for rheumatologists) was from the frustration of the archaic technologies we have been using in our medical practices (including user hostile EHRs), compared to the rapid advancing pace of the consumer technologies we use at home. So came the struggle to adapt affordable and usable consumer technology products in the office that would save time (or at least be time neutral) and impact
Dr. Joseph Smolen delivered one of the most elegant and informative talk on rheumatoid arthritis at this ACR’s meeting as a tribute to Dr. Paul Klemperer. Dr. Smolen led us on a journey, and had us feeling content with what we are doing in practice as we walked with him from historical discoveries of RA through new drug development. Then Dr. Smolen did the unthinkable: he made us crash!
Dr. Janet Pope: TB Testing and TNF Inhibitors
Dr. Janet Pope discusses a study on TB testing prior to TNF inhibitors, as presented at the ACR/ARHP Annual Meeting in Chicago.
Dr. Naomi Schlesinger: Gout Trials
Dr. Naomi Schlesinger discusses gout treatment studies at the ACR/ARHP Annual Meeting in Chicago.
Dr. John Goldman: Autoantibodies
Dr. John Goldman discusses an autoantibodies presentation from the ACR/ARHP Annual Meeting in Chicago.
Dr. Arthur Lau: Osteoporosis
Dr. Arthur Lau discusses osteoporosis studies presented at the ACR/ARHP Annual Meeting in Chicago.
Dr. Ian Bruce: JAK Inhibitors
Dr. Ian Bruce discusses JAK inhibitor at the ACR/ARHP Annual Meeting in Chicago.
Dr. Cassie Calabrese: Gout
Dr. Cassie Calabrese discusses gout studies at the ACR/ARHP Annual Meeting in Chicago.
Dr. Jack Cush interviews Lilly Executive Dr. Ajay Nirula
Dr. Jack Cush interviews Dr. Ajay Nirula, vice president of immunology of Eli Lilly and Company.
Dr. Atul Deodhar: Inflammatory Bowel Disease
Dr. Atul Deodhar talks about inflammatory bowel disease in patients receiving IL-17 inhibitors (abstract 1866) at the ACR/ARHP Annual Meeting in Chicago.
